Search research articles
Contact Us
Filters
Showing results (191-200 of 201) with videos related to
Page
of 21
Sort By:
ESMO Open
|
March 27, 2026
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study
F Moik, F Huemer, B Doleschal, et al.
Plos Pathogens
|
October 1, 2020
Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms
Emily R Bowman, Cheryl M Cameron, Brian Richardson, et al.
Allergy
|
January 11, 2018
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update
M Maurer, M Magerl, I Ansotegui, et al.
Arerugi = [Allergy]
|
March 17, 2023
M Maurer, M Magerl, I Ansotegui, et al.
Cancers
|
December 28, 2019
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models
Maria Anna Smolle, Michiel van de Sande, Dario Callegaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitors
J M Riedl, F Fece de la Cruz, J J Lin, et al.
Cancer Discovery
|
January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators
Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 26, 2024
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
T Buttgereit, F Aulenbacher, A Gutsche, et al.
Arerugi = [Allergy]
|
September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Arerugi = [Allergy]
|
May 24, 2023
M Maurer, M Magerl, S Betschel, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 201) with videos related to
Sort By:
Page
of 21
ESMO Open
|
March 27, 2026
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study
F Moik, F Huemer, B Doleschal, et al.
Plos Pathogens
|
October 1, 2020
Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms
Emily R Bowman, Cheryl M Cameron, Brian Richardson, et al.
Allergy
|
January 11, 2018
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update
M Maurer, M Magerl, I Ansotegui, et al.
Arerugi = [Allergy]
|
March 17, 2023
M Maurer, M Magerl, I Ansotegui, et al.
Cancers
|
December 28, 2019
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models
Maria Anna Smolle, Michiel van de Sande, Dario Callegaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitors
J M Riedl, F Fece de la Cruz, J J Lin, et al.
Cancer Discovery
|
January 8, 2026
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators
Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 26, 2024
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
T Buttgereit, F Aulenbacher, A Gutsche, et al.
Arerugi = [Allergy]
|
September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Arerugi = [Allergy]
|
May 24, 2023
M Maurer, M Magerl, S Betschel, et al.
Page
of 21